Document ID: chunk:federal_register_of_legislation:F2025L00149:front:0:p7
Version: federal_register_of_legislation:F2025L00149
Segment Type: other
Provision Reference: 
Character Range: 18330–21582

years before clinical onset or clinical worsening;
 2.       having periodontitis for at least the 5 years before clinical onset or clinical worsening;
 3.       having gout or hyperuricaemia for at least the 5 years before clinical onset or clinical worsening;
Note: hyperuricaemia is defined in the Schedule 1 - Dictionary.
 1.       undertaking physical activity of 5 METS or more within the 24 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
Note: MET (metabolic equivalent) is a unit of measure of the level of physical capability of the cardiorespiratory system. For example, 1 MET = cardiorespiratory effort associated with a person sitting, 3-4 METs = cardiorespiratory effort associated with a person walking at average walking pace (5 km/h) or light gardening.
 1.       experiencing a category 1A stressor within the 48 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
Note: category 1A stressor is defined in the Schedule 1 - Dictionary.
 1.       experiencing a category 1B stressor within the 48 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
Note: category 1B stressor is defined in the Schedule 1 - Dictionary.
 1.       experiencing an acute severe stressful event that causes a sudden, intense emotional or psychological response within the 24 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
 2.       experiencing the death of a family member or close friend within the 4 weeks before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
 3.       using one of the following illicit drugs within the 24 hours before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease:
         1.           amphetamines or amphetamine derivatives, including methamphetamine, 3, 4-methylenedioxymethamphetamine (Ecstasy or MDMA);
         2.           cocaine;
         3.           D-lysergic acid diethylamide;
         4.           marijuana;
         5.           Khat and synthetic cathinones, including alpha-pyrrolidinopentiophenone, 4- methylmethcathinone (4-MMC), and 3-methylmethcathinone (3-MMC).
 4.       having an episode of acute cholinergic poisoning from exposure to an organophosphorus ester within the 1 week before the clinical onset or the clinical worsening of acute coronary syndrome (including myocardial infarction) or sudden death from ischaemic heart disease;
Note: acute cholinergic poisoning and organophosphorus ester are defined in the Schedule 1 - Dictionary.
 1.       being exposed to:
         1.           an ambient temperature of 38 degrees Celsius or above; or
         2.           an ambient temperature of zero degrees Celsius or below;
for a